Literature DB >> 4951413

"Tertiary" hyperparathyroidism induced by osteomalacia resulting from phosphorus depletion.

G D Ludwig, C G Kyle, M de Blanco.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4951413     DOI: 10.1016/0002-9343(67)90155-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  9 in total

1.  [The analyses of aluminum in serum and urine for monitoring of exposed persons (author's transl)].

Authors:  H Valentin; P Preusser; K H Schaller
Journal:  Int Arch Occup Environ Health       Date:  1976-10-21       Impact factor: 3.015

Review 2.  Antacid-induced osteomalacia.

Authors:  Y Boutsen; J P Devogelaer; J Malghem; H Noel; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

Review 3.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

Review 4.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

5.  Antacid induction of phosphate depletion syndrome in renal failure.

Authors:  D E Abrams; R B Silcott; R Terry; T V Berne; B H Barbour
Journal:  West J Med       Date:  1974-02

Review 6.  Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature.

Authors:  A Chines; R Pacifici
Journal:  Calcif Tissue Int       Date:  1990-11       Impact factor: 4.333

7.  Tertiary hyperparathyroidism.

Authors:  D R Davies; C E Dent; L Watson
Journal:  Br Med J       Date:  1968-08-17

8.  Hypocalcaemic primary hyperparathyroidism.

Authors:  W M Keynes; F I Caird
Journal:  Br Med J       Date:  1970-01-24

9.  Increased prothrombin time and metabolic changes with high serum aluminum levels following long-term exposure to Bayer-process alumina.

Authors:  D Waldron-Edward; P Chan; S C Skoryna
Journal:  Can Med Assoc J       Date:  1971-12-18       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.